Hypoxia-induced redox alterations and their correlation with 99mTc-MIBI and 99mTc-HL-91 uptake in colon cancer cells

Nuclear Medicine and Biology

Volumn 37, Issue 2, 2010, Pages 125-132

  Abrantes, Ana Margarida ^a,c   Serra, Maria Elisa Silva ^b   Gonçalves, Ana Cristina ^c   Rio, Joana ^a   Oliveiros, Bárbara ^a   Laranjo, Mafalda ^a   Rocha Gonsalves, António Manuel ^b,c   Sarmento Ribeiro, Ana Bela ^c   Botelho, Maria Filomena ^a,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

99mTc HL91; Functional imaging; Mitochondrial dysfunction; Nuclear medicine; Oxidative stress; Tumoural hypoxia

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PIMONIDAZOLE; REACTIVE OXYGEN METABOLITE; UPENAZIME TC 99M;

APOPTOSIS; ARTICLE; CANCER CELL; CELL HYPOXIA; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG UPTAKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS;

ANIMALS; BIOLOGICAL TRANSPORT; CELL DEATH; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; FLOW CYTOMETRY; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; ORGANOTECHNETIUM COMPOUNDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXIMES; REACTIVE OXYGEN SPECIES; TECHNETIUM TC 99M SESTAMIBI;

EID: 76949092642     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2009.11.001     Document Type: Article

References (39)

1. Arnold C.N., Goel A., Blum H.E., and Boland C.R. Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. Cancer 104 (2005) 2035-2047
2. Ljungkvist A.S., Bussink J., Kaanders J.H., Rijken P.F., Begg A.C., Raleigh J.A., et al. Hypoxic cell turnover in different solid tumor lines. Int J Radiat Oncol Biol Phys 62 (2005) 1157-1168
3. Goethals L., Debucquoy A., Perneel C., Geboes K., Ectors N., De Schutter H., et al. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. Int J Radiat Oncol Biol Phys 65 (2006) 246-254
4. Kizaka-Kondoh S., Inoue M., Harada H., and Hiraoka M. Tumor hypoxia: a target for selective cancer therapy. Cancer Sci 94 (2003) 1021-1028
5. Jain R.K. Determinants of tumor blood flow: a review. Cancer Res 48 (1988) 2641-2658
6. Yu J.L., Rak J.W., Carmeliet P., Nagy A., Kerbel R.S., and Coomber B.L. Heterogeneous vascular dependence of tumor cell populations. Am J Pathol 158 (2001) 1325-1334
7. Vaupel P., Thews O., and Hoeckel M. Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 18 (2001) 243-259
8. Blankenberg F.G., and Strauss H.W. Nuclear medicine applications in molecular imaging: 2007 update. Q J Nucl Med Mol Imaging 51 (2007) 99-110
9. Airley R.E., and Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy 53 (2007) 233-256
10. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 3 (1997) 177-182
11. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312 (1985) 159-163
12. Waleh N.S., Calaoagan J., Murphy B.J., Knapp A.M., Sutherland R.M., and Laderoute K.R. The redox-sensitive human antioxidant responsive element induces gene expression under low oxygen conditions. Carcinogenesis 19 (1998) 1333-1337
13. Olive P.L., and Aquino-Parsons C. Measurement of tumor hypoxia using single-cell methods. Semin Radiat Oncol 14 (2004) 241-248
14. Vikram D.S., Zweier J.L., and Kuppusamy P. Methods for noninvasive imaging of tissue hypoxia. Antioxid Redox Signal 9 (2007) 1745-1756
15. Stone H.B., Brown J.M., Phillips T.L., and Sutherland R.M. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res 136 (1993) 422-434
16. Jurisson S.S., and Lydon J.D. Potential technetium small molecule radiopharmaceuticals. Chem Rev 99 (1999) 2205-2218
17. 99mTc]N-benzyl-3,4-di-(N-2-mercaptoethyl)-amino-pyrrolidines (P-BAT). Nucl Med Biol 26 (1999) 217-224
18. 99mTc(CO)3 complex of 2-methyl-5-nitroimidazole as an agent for targeting tumor hypoxia. Bioorg Med Chem 14 (2006) 7666-7670
19. Reichert D., Lewis J.S., and Anderson C.J. Metal complexes as diagnostic tools. Coord Chem Rev 184 (1999) 3-66
20. Méndez-Rojas M.A., Kharisov B.I., and Tsivadze A.Y. Recent advances on technetium complexes: coordination chemistry and medical applications. J Coord Chem 59 (2006) 1-63
21. Chapman J.D. Hypoxic sensitizers-implications for radiation therapy. N Engl J Med 301 (1979) 1429-1432
22. Ballinger J.R. Imaging hypoxia in tumors. Semin Nucl Med 31 (2001) 321-329
23. Nanjappan P., Raju N., Ramalingam K., and Nowotnik D.P. An efficient synthesis of some 6-substituted 4,8-diaza-3,3,9,9-tetramethylundeca-2,10-dione dioximes (propylene amine oximes, Pnaos) - ligands for Tc-99m complexes used in structure distribution relationship (Sdr) studies. Tetrahedron 50 (1994) 8617-8632
24. Archer C.M., Binke J.F., Canning L.R., Edwards B., and King A.C. Radiometal complexes that localize in hypoxic tissues. US Patent 5997843 (1999)
25. 99mTc-PnAO); a potential brain radiopharmaceutical. Eur J Nucl Med 9 (1984) 511-516
26. Archer C., Edwards B., Kelly J.D., King A.C., Burke J.F., and Riley A.L.M. Technetium labelled agents for imaging tissue hypoxia in vivo (1995), SGE Ditoriali Publishers 535-539
27. Piwnica-Worms D., Chiu M.L., Budding M., Kronauge J.F., Kramer R.A., and Croop J.M. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 53 (1993) 977-984
28. Aubry J.P., Blaecke H., Lecoanet-Henchoz S., Jeannin P., Herbault N., Caron G., et al. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry 37 (1999) 197-204
29. Halliwell B., and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol 142 (2004) 231-255
30. Heerlein K., Schulze A., Hotz L., Bartsch P., and Mairbaurl H. Hypoxia decreases cellular ATP demand and inhibits mitochondrial respiration of a549 cells. Am J Respir Cell Mol Biol 32 (2005) 44-51
31. Cook G.J., Houston S., Barrington S.F., and Fogelman I. Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG. J Nucl Med 39 (1998) 99-103
32. Vaupel P. Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist 13 Suppl 3 (2008) 21-26
33. Hung T.H., Skepper J.N., Charnock-Jones D.S., and Burton G.J. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90 (2002) 1274-1281
34. Kinuya S., Yokoyama K., Li X.F., Bai J., Watanabe N., Shuke N., et al. Hypoxia-induced alteration of tracer accumulation in cultured cancer cells and xenografts in mice: implications for pre-therapeutic prediction of treatment outcomes with (99m)Tc-sestamibi, (201)Tl chloride and (99m)Tc-HL91. Eur J Nucl Med Mol Imaging 29 (2002) 1006-1011
35. Murphy B.J., Robin E.D., Tapper D.P., Wong R.J., and Clayton D.A. Hypoxic coordinate regulation of mitochondrial enzymes in mammalian cells. Science 223 (1984) 707-709
36. 2. J Clin Invest 59 (1977) 443-448
37. Acosta D., and Li C.P. Injury to primary cultures of rat heart endothelial cells by hypoxia and glucose deprivation. In Vitro 15 (1979) 929-934
38. Weinmann M., Jendrossek V., Guner D., Goecke B., and Belka C. Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways. FASEB J 18 (2004) 1906-1908
39. Lluis J.M., Buricchi F., Chiarugi P., Morales A., and Fernandez-Checa J.C. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death. Cancer Res 67 (2007) 7368-7377